Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer

Anaplastic thyroid cancer (ATC) has perhaps the worst prognosis of any cancer, with a median survival of only about 5 months regardless of stage. Pazopanib monotherapy has promising clinical activity in differentiated thyroid cancers (generally attributed to vascular endothelial growth factor recept...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Isham, Crescent R., Bossou, Ayoko R., Negron, Vivian, Fisher, Kelly E., Kumar, Rakesh, Marlow, Laura, Lingle, Wilma L., Smallridge, Robert C., Sherman, Eric J., Suman, Vera J., Copland, John A., Bible, Keith C.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3905331/
https://ncbi.nlm.nih.gov/pubmed/23283368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3004358
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares